Key result
Surgical resection followed by chemotherapy led to clinical improvement in a 52-year-old patient with a rare primary cardiac diffuse large B-cell lymphoma.
Why the study?
Disease that primarily originates from the heart is rare and therefore poses a diagnostic challenge.
Case Report (n=1)
Primary cardiac lymphoma is a rare condition that can present as a right heart mass and be successfully managed with surgical resection and chemotherapy.
Answers are grounded in this paper and cite their sources.
Supports multimodal therapy in rare primary cardiac lymphoma; leaves open optimal strategies pending larger studies.
INTRODUCTION AND IMPORTANCE: Lymphoma can either be Hodgkin or non-Hodgkin (NHL) with diffuse large B cell lymphoma (DLBL) being a type of the latter with an aggressive behavior. Although NHL involvement of the heart in late stages is not uncommon, disease that primarily originates from the heart is rare and therefore poses a diagnostic challenge. CASE PRESENTATION: Herein, we report the case of a 52-year-old patient who presented to the hospital with non-specific signs and symptoms and was found to have a heterogeneous echogenic irregular mass across the tricuspid valve in the right atrium and right ventricle. The majority of the mass was located in the right atrium, with the tip attached to the right ventricular free wall near the tricuspid annulus. Initially thought to be an atrial myxoma but later confirmed histologically to be diffuse large B cell Lymphoma, and the patient underwent right atrial mass resection, followed by chemotherapy. The patient showed improvement following treatment. CLINICAL DISCUSSION: Primary cardiac lymphoma (PCL) is a rare form of lymphoma that is confined exclusively to the heart and/or pericardium, without the involvement of other lymph nodes or extra-nodal tissues or organs. Pathological analysis confirms PCL as either non-Hodgkin's lymphoma (NHL) or Hodgkin's lymphoma (HL). PCL accounts for approximately 1.3 % of primary cardiac tumors and 0.5 % of extra-nodal lymphomas. CONCLUSION: Our case report provides valuable insights for clinicians to better understand this uncommon disease and reduce the incidence of misdiagnosis.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2023) conducted a case report in Primary cardiac diffuse large B-cell lymphoma (n=1). Surgical resection and chemotherapy was evaluated on Clinical improvement. Surgical resection followed by chemotherapy led to clinical improvement in a 52-year-old patient with a rare primary cardiac diffuse large B-cell lymphoma.
Synapse has enriched 10 related papers. Consider them for comparative context: